Other
DW-MRI
DW-MRI is an intervention with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
7
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
1(14%)
Results Posted
0%(0 trials)
Terminated
2(29%)
Phase Distribution
Ph not_applicable
4
57%
Ph early_phase_1
1
14%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
7
all time
Status Distribution
Active(2)
Completed(2)
Terminated(2)
Other(1)
Detailed Status
Terminated2
Completed2
unknown1
Enrolling by invitation1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
7
Active
1
Success Rate
50.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (20.0%)
N/A4 (80.0%)
Trials by Status
terminated229%
unknown114%
completed229%
enrolling_by_invitation114%
recruiting114%
Recent Activity
1 active trials
Showing 5 of 7
enrolling_by_invitationnot_applicable
Li-Fraumeni Syndrome Imaging Study
NCT03176836
recruitingnot_applicable
Characterization of Placental Diffusion
NCT06992245
completed
Diffusion-Weighted MRI for Liver Metastasis
NCT02781935
terminatedearly_phase_1
3T MRI Biomarkers of Glioma Treatment Response
NCT01996527
terminatednot_applicable
Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses
NCT02218502
Clinical Trials (7)
Showing 7 of 7 trials
NCT03176836Not Applicable
Li-Fraumeni Syndrome Imaging Study
NCT06992245Not Applicable
Characterization of Placental Diffusion
NCT02781935
Diffusion-Weighted MRI for Liver Metastasis
NCT01996527Early Phase 1
3T MRI Biomarkers of Glioma Treatment Response
NCT02218502Not Applicable
Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses
NCT02527057
Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT01829412Not Applicable
Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma
All 7 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 7